Merck plans to conduct clinical trials of a novel investigational HPV vaccine for GARDASIL9
Company reaffirms commitment to reduce the global burden of HPV-related diseases, including certain cancers
Company reaffirms commitment to reduce the global burden of HPV-related diseases, including certain cancers
The Indian government will float a global tender in April 2023 to procure HPV vaccines.
This could be a game-changer for the prevention of the disease; seeing more doses of the life-saving jab reach more girls
Supply increase to help meet growing global demand
This recognition marks the third time in five years that Merck has been included on Fortune’s Change the World list.
India’s first gender-neutral HPV vaccine to help reduce HPV -related disease burden in Indian girls, women and boys
Subscribe To Our Newsletter & Stay Updated